Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

386
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
386
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

368
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
368
Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

335
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
335
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

324
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
324
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

388
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
388

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Chinese gallnuts tannic acids on the growth performance, intestinal morphometry and microbiome of broiler chickens.

Poultry science·2026
Same author

Food insecurity, epigenetic age acceleration, and depression in middle-aged and older adults: a longitudinal cohort study.

Frontiers in nutrition·2026
Same author

Prevalence and Genomic Characterization of mcr-1-Positive Escherichia coli from Livestock in Hunan Province, China (2016-2021).

Current microbiology·2026
Same author

Identification of a rare missense variant in the gene SPATA31H1 associated with hereditary gingival fibromatosis in a large Chinese family.

BMC oral health·2026
Same author

Eliciting ferroptosis with a visual magnetic nanogel to sensitize triple negative breast cancer to taxol by blocking extracellular vesicle-mediated iron efflux.

Colloids and surfaces. B, Biointerfaces·2026
Same author

LNP-based delivery of a Toll-like receptor 9 agonist elicits potent adjuvant effects and antitumor immunity.

NPJ vaccines·2026

Related Experiment Video

Updated: Mar 30, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

809

Optimal adaptive sequential designs for crossover bioequivalence studies.

Jialin Xu1, Charles Audet2, Charles E DiLiberti3

  • 1Merck & Co., Inc.,, Upper Gwynedd, PA,, USA.

Pharmaceutical Statistics
|November 6, 2015
PubMed
Summary

Optimized adaptive sequential designs for crossover bioequivalence studies improve performance. These new designs maintain statistical validity and power while reducing average sample sizes compared to traditional methods.

Keywords:
adaptive designbioequivalencesample size re-estimationsequential design

More Related Videos

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
06:18

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

1.0K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.2K

Related Experiment Videos

Last Updated: Mar 30, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

809
Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR
06:18

Frequency and Distribution of Crossovers in Caenorhabditis elegans Meiosis by SNP Genotyping using Real-time PCR

Published on: July 11, 2025

1.0K
A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM
13:54

A Workflow for Lipid Nanoparticle LNP Formulation Optimization using Designed Mixture-Process Experiments and Self-Validated Ensemble Models SVEM

Published on: August 18, 2023

6.2K

Area of Science:

  • Pharmacokinetics and Drug Development
  • Biostatistics
  • Clinical Trial Design

Background:

  • Adaptive sequential designs offer flexibility in bioequivalence studies.
  • Previous work established the feasibility of such designs for crossover trials.

Purpose of the Study:

  • To optimize adaptive sequential designs for crossover bioequivalence studies.
  • To evaluate designs across various geometric mean ratios (GMRs) and intra-subject variation levels.
  • To incorporate futility rules and study size limits into adaptive designs.

Main Methods:

  • Optimization of adaptive sequential designs for bioequivalence.
  • Evaluation across GMRs (70-143%) and intra-subject coefficients of variation (10-30%, 30-55%).
  • Inclusion of futility stopping rules and maximum study size constraints.

Main Results:

  • Optimized designs demonstrated superior performance characteristics.
  • Type I error was not unduly inflated, and power remained at or above 80%.
  • Average sample sizes were comparable to or smaller than conventional single-stage designs.

Conclusions:

  • Optimized adaptive sequential designs provide an efficient approach for crossover bioequivalence studies.
  • These designs balance statistical rigor with reduced sample size requirements.
  • The inclusion of futility and size limits enhances practical application.